Home
>
National Drug Code (NDC)
>
Exelon
Exelon - 0078-0503-15 - (rivastigmine)
Drug Information of Exelon
| Product NDC: | 0078-0503 |
| Proprietary Name: | Exelon |
| Non Proprietary Name: | rivastigmine |
| Active Ingredient(s): | 13.3 mg/24h & nbsp; rivastigmine |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Exelon
| Product NDC: | 0078-0503 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022083 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120831 |
Package Information of Exelon
| Package NDC: | 0078-0503-15 |
| Package Description: | 30 PATCH in 1 CARTON (0078-0503-15) > 48 h in 1 PATCH (0078-0503-61) |
NDC Information of Exelon
| NDC Code | 0078-0503-15 |
| Proprietary Name | Exelon |
| Package Description | 30 PATCH in 1 CARTON (0078-0503-15) > 48 h in 1 PATCH (0078-0503-61) |
| Product NDC | 0078-0503 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rivastigmine |
| Dosage Form Name | PATCH, EXTENDED RELEASE |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20120831 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | RIVASTIGMINE |
| Strength Number | 13.3 |
| Strength Unit | mg/24h |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
